Prof. Taner Korkmaz is an accomplished medical oncologist with a strong academic and clinical background. He earned promotion to Associate Professor in 2012 and brings extensive experience from his work with the Acibadem Health Group since 2014. Prof. Korkmaz is actively involved in the global oncology community through memberships in the Turkish Medical Oncology society, the American Society of Clinical Oncology (ASCO), the European School of Oncology, and the European Society for Medical Oncology (ESMO). He is committed to evidence-based cancer care, multidisciplinary collaboration, and ongoing professional development to deliver the best outcomes for his patients.
Education
- 2012 Associate Professor
- 2011 Marmara University Faculty of Medicine Medical Oncology
- 2003 Istanbul Training and Research Hospital Internal Medicine
- 1999 Ege University Faculty of Medicine
Experience
- 2014 Acibadem Health Group
- 2011 – 2014 Dr. Lütfi Kırdar Kartal Training and Research Hospital
- 2005 – 2008 Okmeydanı Training and Research Hospital
- 2004 – 2005 Derince 100-Bed Military Hospital
- 2004 Ministry of Health Great Island Dispensary
Memberships
- Turkish Medical Oncology
- American Society of Clinical Oncology
- European School of Oncology
- European Society of Medical Oncology
Publications
- Primary renal carcinoid: treatment and
Crit Rev Oncol Hematol. 2013 Sep;87(3):256-64. doi: 10.1016/j.critrevonc.2013.02.003. AL Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS. - Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis.
Diagn Pathol. 2013 Sep 17;8(1):151. [Epub ahead of print] Karaday N, Kandem R NO, Yavuzer D, Korkmaz T, Gecmen G, Kokturk F. - Association between human papillomavirus and endometrial adenocarcinoma.
Med Oncol. 2013 Sep;30(3):597.doi:10.1007/sl2032-013-0597-5.Epub2013Jun25 Karadayi N, Gecer M, Kayahan S, Yamuc E, Onak NK, Korkmaz T, Yavuzer D. - Serum Thymidine Kinase 1 Levels Correlates With FDG Uptake And Prognosis In Patients With Non Small Cell Lung Cancer
Biomarkers (ISI), 88-94 pp., 2012 , DOI: 10.3109/1354750X.2012.738250 T. Korkmaz , S. Seber, K. Okutur, G. Basaran, P.F. Yumuk, F. Dane , T. Ones, O. Polat, O.C. Madenci, G. - Prognostic role of initial PET/CT SUV max Value in Metastatic Gastric Adenocarcinoma
Dane , O. Polat, O. Kanat, M. Gumus, G. Demir, N.S. Turhal / MOJ , 35-39 pp., 2012 Korkmaz , S. Seber , K. Okutur, M. Canhoroz, A. Bilici, T. Toptas, G. Basaran, F. Dede, F. Yumuk, F - Breast cancer diabetes insipidus case with normal hypothalamo-hypophysial axis
Case Study and Case Report , 143-147 pp., 2012 Korkmaz, K. Ekici, S. Seber, M Banzragch, S. Kazan, E. Dizen, A. Mayadagli - Comparison of second line treatment outcomes between sensitive and refractory small cell lung cancer patients :a retrospective analysis.
Sener, S. Yuksel, A. Mert, O. Polat, F. Yumuk, O. Kanat, M. Gumus, N.S. TurhalClinical and Translational Oncology (ISI), 2012 , DOI: 10.1007/s12094-01 T.Korkmaz ,S.Seber, U.Kefeli, E. Sari, M. Canhoroz, B. Oven, E. Yildirim, N. Yasar, D. Aydin, O. Balvan, N. - Netrin-1 Concentrations in patients with advanced gastric cancer and its relation with treatment
T.Korkmaz, R. Yildiz, M. Gumus / Biomarkers (ISI), 663-7 pp, 2012 , DOI: 10.3109/1354750X.2012.709882 Kefeli, M.E. Yildirim, D. Aydin, O.C. Madenci, N. Yasar, N. Sener, A.G. Mert, S. Yuksel, O. B. Ercelep, T. - Clinical outcome of breast cancer patients with N3a (^10 positive lymph nodes)
Dane ,F.P. Yumuk, S.N. Turhal / Medical Oncology (ISI), 726-732 pp., 2011 , DOI: 10.1007/s12032-010- G. Basaran , D. Cabuk, H.B. Caglar, B. Gulluoglu , H. Kaya , S. Seber, T. Korkmaz ,F. Telli.M. Kocak F., - A 24-Year-Old Case of Newly Diagnosed Tetralogy of Fallot with No Complications
Okmeydanı Tıp Dergisi 2006;23(3); pp33-36 A.S. Arar, M. Adas, N. Ozsoy, T. Korkmaz, A.N. Dursun, A. Helvaci
